NM_003742.4:c.2815-236G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003742.4(ABCB11):c.2815-236G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.171 in 152,008 control chromosomes in the GnomAD database, including 2,740 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2740 hom., cov: 32)
Consequence
ABCB11
NM_003742.4 intron
NM_003742.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.27
Publications
23 publications found
Genes affected
ABCB11 (HGNC:42): (ATP binding cassette subfamily B member 11) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is the major canalicular bile salt export pump in man. Mutations in this gene cause a form of progressive familial intrahepatic cholestases which are a group of inherited disorders with severe cholestatic liver disease from early infancy. [provided by RefSeq, Jul 2008]
ABCB11 Gene-Disease associations (from GenCC):
- progressive familial intrahepatic cholestasis type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- benign recurrent intrahepatic cholestasis type 2Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-168935661-C-T is Benign according to our data. Variant chr2-168935661-C-T is described in ClinVar as Benign. ClinVar VariationId is 1241955.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.308 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ABCB11 | ENST00000650372.1 | c.2815-236G>A | intron_variant | Intron 22 of 27 | NM_003742.4 | ENSP00000497931.1 | ||||
| ABCB11 | ENST00000649448.1 | c.1132-236G>A | intron_variant | Intron 8 of 14 | ENSP00000497165.1 | |||||
| ABCB11 | ENST00000439188.1 | n.*1285-236G>A | intron_variant | Intron 9 of 14 | 2 | ENSP00000416058.1 |
Frequencies
GnomAD3 genomes AF: 0.171 AC: 25994AN: 151888Hom.: 2734 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
25994
AN:
151888
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.171 AC: 26041AN: 152008Hom.: 2740 Cov.: 32 AF XY: 0.172 AC XY: 12782AN XY: 74288 show subpopulations
GnomAD4 genome
AF:
AC:
26041
AN:
152008
Hom.:
Cov.:
32
AF XY:
AC XY:
12782
AN XY:
74288
show subpopulations
African (AFR)
AF:
AC:
11549
AN:
41426
American (AMR)
AF:
AC:
3041
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
403
AN:
3472
East Asian (EAS)
AF:
AC:
1651
AN:
5140
South Asian (SAS)
AF:
AC:
694
AN:
4810
European-Finnish (FIN)
AF:
AC:
1135
AN:
10580
Middle Eastern (MID)
AF:
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7176
AN:
67990
Other (OTH)
AF:
AC:
338
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1057
2114
3171
4228
5285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
268
536
804
1072
1340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
750
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.